Levels of toxins in oral tobacco products in the UK

Tobacco Control

Volumn 15, Issue 1, 2006, Pages 64-67

  McNeill, A ^a   Bedi, Raman ^b   Islam, S ^b   Alkhatib, M N ^b   West, R ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BENZO[A]PYRENE; CARCINOGEN; HEAVY METAL; NICOTINE; NITROSAMINE;

ARTICLE; ASIA; BIOAVAILABILITY; CHEMISTRY; ETHNOLOGY; HUMAN; SMOKELESS TOBACCO; UNITED KINGDOM;

ASIA; BENZO(A)PYRENE; BIOLOGICAL AVAILABILITY; CARCINOGENS; GREAT BRITAIN; HUMANS; METALS, HEAVY; NICOTINE; NITROSAMINES; TOBACCO, SMOKELESS;

EID: 31944442073     PISSN: 09644563     EISSN: None     Source Type: Journal    
DOI: 10.1136/tc.2005.013011     Document Type: Article

References (17)

1. Stepanov I, Hecht SS, Ramakrishnan S, et al. Tobacco-specific nitrosamines in smokeless tobacco products marketed in India. Int J Cancer 2005;116:16-19.
2. Bedi R, Gilthorpe MS. The prevalence of betel-quid and tobacco chewing among the Bangladeshi community resident in a United Kingdom area of multiple deprivation. Prim Dent Care 1995;2:39-42.
3. The European Parliament and the Council of the European Union. Directive 2001/37/EC of the European Parliament of the Council of 5th June 2001 on the approximation of the laws, regulations and administrative provisions of the Member States concerning the laws, regulations and administrative provisions of the Member States concerning the manufacture, presentation and sale of tobacco products. Luxembourg (2001). http://europa.eu.int/eur-lex/pri/en/oj/dat/2001/ l_194/l_19420010718en00260034.pdf.
4. Gupta PC, Ray CS. Smokeless tobacco and health in India and South Asia. Respirology 2003;8:419-31.
5. Brunnemann KD, Hoffman D. Analytical studies on tobacco-specific N-nitrosamines in tobacco and tobacco smoke. Crit Rev Toxicol 1991;21:235-40.
6. Hoffmann D, Djordjevic MV, Fan J, et al. Five leading US commercial brands of moist snuff in 1994: assessment of carcinogenic N-nitrosamines. J Natl Cancer Inst 1995;87:1862-9.
7. Swedish Match. The Gothiatek Standard, http://www.gothiatek.com/ templates/index2.aspx?page_id=488&fromfirst=1.
8. Star Scientific. http://www.starscientific.com/frame-pages/about_frame. htm.
9. Osterdahl B-G, Jansson C, Paccou A. Decreased levels of tobacco-specific N-nitrosamines in moist snuff on the Swedish market. J Agric Food Chem 2004;52:5085-8.
10. Hatsukami DK, Lemmonds C, Zhang Y, et al. Evaluation of carcinogen exposure in people who used 'reduced exposure' tobacco products. J Natl Cancer Inst 2004;96:844-52.
11. Brunnemann KD, Qi J, Hoffmann D. Chemical profile of two types of oral snuff tobacco. Food Chem Toxicol 2002;40:1699-703.
12. Brunnemann KD, Qi J, Hoffmann D. Aging of oral moist snuff and the yields of tobacco-specific N- nitrosamines (TSNA). Progress report prepared for the Massachusetts Tobacco Control Programme, 2001.
13. US Department of Health and Human Agency Centers for Disease Control and Prevention (CDC). Protocol to measure the quantity of nicotine contained in smokeless tobacco products manufactured, imported or packaged in the United States. Federal Register 1997;62:24116-9.
14. Stratton K, Shetty P, Wallace R, et al. Clearing the smoke. Assessing the science base for tobacco harm reduction. Washington DC: Institute of Medicine, National Academy Press, 2001:300.
15. Djordjevic MV, Fan J, Bush LP, et al. Effects of storage conditions on levels of tobacco specific N-nitrosamines and N-nitrosaminoacids in U.S. moist snuff. J Agr Food Chem 1993;41:1790-4.
16. Bates C, Fagerstrom K, Jarvis MJ, et al. European Union policy on smokeless tobacco: a statement in favour of evidence based regulation for public health. Tob Control 2003;12:360-7.
17. West R, McNeill A, Raw M. Smokeless tobacco cessation guidelines for health professionals in England. Br Dent J 2004;196:611-8.